9.16
Certara Inc stock is traded at $9.16, with a volume of 584.51K.
It is up +0.22% in the last 24 hours and down -24.48% over the past month.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.
See More
Previous Close:
$9.14
Open:
$9.14
24h Volume:
584.51K
Relative Volume:
0.29
Market Cap:
$1.46B
Revenue:
$405.76M
Net Income/Loss:
$7.98M
P/E Ratio:
183.20
EPS:
0.05
Net Cash Flow:
$77.47M
1W Performance:
+6.02%
1M Performance:
-24.48%
6M Performance:
-19.12%
1Y Performance:
-18.72%
Certara Inc Stock (CERT) Company Profile
Name
Certara Inc
Sector
Industry
Phone
(415) 237-8272
Address
4 RADNOR CORPORATE CENTER, SUITE 350, RADNOR
Compare CERT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
CERT
Certara Inc
|
9.16 | 1.46B | 405.76M | 7.98M | 77.47M | 0.05 |
|
VEEV
Veeva Systems Inc
|
240.29 | 39.56B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
77.93 | 13.74B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
HQY
Healthequity Inc
|
105.18 | 9.05B | 1.15B | 96.70M | -161.99M | 1.09 |
|
DOCS
Doximity Inc
|
51.44 | 9.60B | 550.17M | 201.35M | 232.07M | 1.00 |
|
WAY
Waystar Holding Corp
|
36.91 | 7.09B | 906.14M | -52.62M | 89.62M | -0.3621 |
Certara Inc Stock (CERT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-21-25 | Initiated | Rothschild & Co Redburn | Buy |
| Nov-13-25 | Initiated | BMO Capital Markets | Market Perform |
| Sep-29-25 | Initiated | Craig Hallum | Buy |
| Jul-03-25 | Resumed | Morgan Stanley | Equal-Weight |
| May-08-25 | Upgrade | Barclays | Equal Weight → Overweight |
| Feb-27-25 | Initiated | TD Cowen | Buy |
| Sep-27-24 | Upgrade | UBS | Neutral → Buy |
| Apr-10-24 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Apr-04-24 | Initiated | JMP Securities | Mkt Perform |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Dec-07-23 | Initiated | UBS | Neutral |
| Dec-05-23 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Aug-22-23 | Downgrade | Jefferies | Buy → Hold |
| Aug-10-23 | Downgrade | William Blair | Outperform → Mkt Perform |
| Apr-12-23 | Initiated | Stephens | Overweight |
| Apr-03-23 | Downgrade | Barclays | Overweight → Equal Weight |
| Dec-14-22 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Sep-08-22 | Initiated | Berenberg | Buy |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Jul-01-22 | Initiated | Piper Sandler | Overweight |
| Jan-11-22 | Upgrade | Jefferies | Hold → Buy |
| Aug-05-21 | Resumed | Credit Suisse | Neutral |
| Jul-23-21 | Initiated | Robert W. Baird | Outperform |
| Mar-03-21 | Initiated | Barclays | Overweight |
| Jan-06-21 | Initiated | Morgan Stanley | Equal-Weight |
| Jan-05-21 | Initiated | BofA Securities | Buy |
| Jan-05-21 | Initiated | Credit Suisse | Neutral |
| Jan-05-21 | Initiated | Jefferies | Hold |
| Jan-05-21 | Initiated | William Blair | Outperform |
View All
Certara Inc Stock (CERT) Latest News
Certara, Inc. (CERT) Stock forecasts - Yahoo Finance UK
In Silico Clinical Trials Market Size to Reach $6.68 Billion by 2032 – SNS Insider - GlobeNewswire Inc.
Certara, Inc. (CERT) Stock Forecasts - Yahoo Finance
Can Certara Inc. stock surprise with earnings upsideWeekly Investment Recap & Real-Time Stock Entry Alerts - moha.gov.vn
Certara Inc (CERT) is looking forward to a strong quarter - Setenews
Certara (NASDAQ:CERT) Upgraded to Buy at Wall Street Zen - Defense World
Certara (NASDAQ:CERT) Coverage Initiated at Rothschild & Co Redburn - Defense World
Certara’s Earnings Call: Mixed Sentiment Amid Growth - MSN
Certara, Inc. $CERT Shares Sold by Bank of Montreal Can - Defense World
Rothschild Redburn initiates Certara stock with Buy rating on biosimulation leadership By Investing.com - Investing.com South Africa
Rothschild Redburn initiates Certara stock with Buy rating on biosimulation leadership - Investing.com Canada
Risk adjusted return profile for Certara Inc. analyzedTrade Analysis Report & Free Low Drawdown Momentum Trade Ideas - newser.com
Can Certara Inc. stock sustain revenue growthWeekly Trend Recap & Step-by-Step Swing Trade Plans - newser.com
Will Certara Inc. stock deliver long term returnsJuly 2025 Sector Moves & Growth Focused Stock Reports - newser.com
Will Certara Inc. stock benefit from AI adoptionEarnings Recap Report & Daily Volume Surge Signals - newser.com
Certara at Stephens Annual Investment Conference: AI Drives Growth Amid Challenges By Investing.com - Investing.com Nigeria
Certara at Jefferies London: Strategic Focus Amid Market Challenges By Investing.com - Investing.com Australia
Certara at Jefferies London: Strategic Focus Amid Market Challenges - Investing.com India
Jefferies Global Healthcare Conference - MarketScreener
Certara stock hits 52-week low at 8.13 USD By Investing.com - Investing.com Canada
Certara narrows 2025 revenue outlook to $415M–$420M as Tier 1 services soften while software and QSP show resilience - MSN
Multi asset correlation models including Certara Inc.July 2025 Technicals & Verified Entry Point Signals - newser.com
Pattern recognition hints at Certara Inc. upsideJuly 2025 WrapUp & Daily Entry Point Trade Alerts - newser.com
Custom watchlist performance reports with Certara Inc.Earnings Miss & AI Forecast Swing Trade Picks - newser.com
Certara (CERT): Evaluating Valuation After Profit Gains and New Biopharma Tech Launches - Sahm
What analysts say about Certara Inc stockPrice-to-Book Ratio Updates & High Return Capital Growth - earlytimes.in
Can Certara Inc. stock sustain institutional interest2025 Market Outlook & Proven Capital Preservation Tips - newser.com
Is Certara Inc. stock trading at a premium valuationMarket Sentiment Review & Weekly Top Gainers Alerts - Fundação Cultural do Pará
Is now a turning point for Certara Inc.Earnings Risk Report & Community Driven Trade Alerts - newser.com
Certara's (NASDAQ:CERT) Earnings May Just Be The Starting Point - Yahoo Finance
Can Certara’s (CERT) Cloud Bet Reshape Its Competitive Edge in Drug Development? - simplywall.st
What technical models suggest about Certara Inc.’s comebackJuly 2025 Closing Moves & Reliable Breakout Forecasts - newser.com
Certara initiated with a Market Perform at BMO Capital - MSN
BMO Capital Initiates Certara at Market Perform - MarketScreener
BMO Capital Initiates Coverage of Certara (CERT) with Market Perform Recommendation - Nasdaq
BMO Capital Initiates Coverage on Certara (CERT) with Market Per - GuruFocus
Insider Buying: William Feehery Acquires Shares of Certara Inc (CERT) - GuruFocus
Certara Inc Stock (CERT) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):